ArticleEuropean journal of clinical pharmacology2006

Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not.

Cordula Meyer zu Schwabedissen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.